Recon Technology, Ltd — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Recon Technology, Ltd filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Jun 30, 2016 | 42.73M | Sep 28, 2016 |
| FY2016 | Jun 30, 2016 | $6.43M | Sep 28, 2016 |
| FY2015 | Jun 30, 2015 | $8.46M | Sep 25, 2015 |
| FY2016 | Jun 30, 2015 | 51.51M | Sep 28, 2016 |
| FY2014 | Jun 30, 2014 | $15.18M | Sep 29, 2014 |
| FY2015 | Jun 30, 2014 | 93.45M | Sep 25, 2015 |
| FY2014 | Jun 30, 2013 | 76.59M | Sep 29, 2014 |
| FY2013 | Jun 30, 2013 | $12.38M | Sep 27, 2013 |
| FY2012 | Jun 30, 2012 | $11.95M | Oct 24, 2012 |
| FY2013 | Jun 30, 2012 | 75.54M | Sep 27, 2013 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Jun 30, 2016 | 7.25M | Sep 28, 2016 |
| FY2016 | Jun 30, 2016 | $1.09M | Sep 28, 2016 |
| FY2016 | Jun 30, 2015 | 10.11M | Sep 28, 2016 |
| FY2015 | Jun 30, 2015 | $1.66M | Sep 25, 2015 |
| FY2015 | Jun 30, 2014 | 32.42M | Sep 25, 2015 |
| FY2014 | Jun 30, 2014 | $5.27M | Sep 29, 2014 |
| FY2014 | Jun 30, 2013 | 25.05M | Sep 29, 2014 |
| FY2013 | Jun 30, 2013 | $4.05M | Sep 27, 2013 |
| FY2013 | Jun 30, 2012 | 24.27M | Sep 27, 2013 |
| FY2012 | Jun 30, 2012 | $3.84M | Oct 24, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Jun 30, 2016 | (40.88M) | Sep 28, 2016 |
| FY2016 | Jun 30, 2016 | ($6.15M) | Sep 28, 2016 |
| FY2016 | Jun 30, 2015 | (31.46M) | Sep 28, 2016 |
| FY2016 | Jun 30, 2015 | ($4.73M) | Sep 28, 2016 |
| FY2014 | Jun 30, 2014 | $131.1K | Sep 29, 2014 |
| FY2015 | Jun 30, 2014 | 807,188 | Sep 25, 2015 |
| FY2014 | Jun 30, 2013 | 39,698 | Sep 29, 2014 |
| FY2013 | Jun 30, 2013 | $6.4K | Sep 27, 2013 |
| FY2013 | Jun 30, 2012 | (3.82M) | Sep 27, 2013 |
| FY2012 | Jun 30, 2012 | ($604.5K) | Oct 24, 2012 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Jun 30, 2016 | (39.91M) | Sep 28, 2016 |
| FY2016 | Jun 30, 2016 | ($6.01M) | Sep 28, 2016 |
| FY2015 | Jun 30, 2015 | ($5.83M) | Sep 25, 2015 |
| FY2016 | Jun 30, 2015 | (35.52M) | Sep 28, 2016 |
| FY2015 | Jun 30, 2014 | 2.83M | Sep 25, 2015 |
| FY2014 | Jun 30, 2014 | $459.8K | Sep 29, 2014 |
| FY2014 | Jun 30, 2013 | (564,747) | Sep 29, 2014 |
| FY2013 | Jun 30, 2013 | ($91.3K) | Sep 27, 2013 |
| FY2013 | Jun 30, 2012 | (3.54M) | Sep 27, 2013 |
| FY2012 | Jun 30, 2012 | ($559.8K) | Oct 24, 2012 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Jun 30, 2016 | 6.86M | Sep 28, 2016 |
| FY2016 | Jun 30, 2016 | $1.03M | Sep 28, 2016 |
| FY2015 | Jun 30, 2015 | $684.7K | Sep 25, 2015 |
| FY2016 | Jun 30, 2015 | 4.17M | Sep 28, 2016 |
| FY2014 | Jun 30, 2014 | $1.32M | Sep 29, 2014 |
| FY2015 | Jun 30, 2014 | 8.09M | Sep 25, 2015 |
| FY2014 | Jun 30, 2013 | 8.51M | Sep 29, 2014 |
| FY2013 | Jun 30, 2013 | $1.38M | Sep 27, 2013 |
| FY2013 | Jun 30, 2012 | 6.27M | Sep 27, 2013 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Jun 30, 2013 | 24.76M | Sep 27, 2013 |
| FY2013 | Jun 30, 2013 | $4.00M | Sep 27, 2013 |
| FY2012 | Jun 30, 2012 | ($3.46M) | Oct 24, 2012 |
| FY2013 | Jun 30, 2012 | (21.70M) | Sep 27, 2013 |
| FY2012 | Jun 30, 2011 | (6.33M) | Oct 24, 2012 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Jun 30, 2016 | 181,075 | Sep 28, 2016 |
| FY2016 | Jun 30, 2016 | $27.3K | Sep 28, 2016 |
| FY2015 | Jun 30, 2015 | $341.3K | Sep 25, 2015 |
| FY2016 | Jun 30, 2015 | 2.08M | Sep 28, 2016 |
| FY2015 | Jun 30, 2014 | 477,957 | Sep 25, 2015 |
| FY2014 | Jun 30, 2014 | $77.7K | Sep 29, 2014 |
| FY2013 | Jun 30, 2013 | $121.8K | Sep 27, 2013 |
| FY2014 | Jun 30, 2013 | 753,583 | Sep 29, 2014 |
| FY2013 | Jun 30, 2012 | 1.03M | Sep 27, 2013 |
| FY2012 | Jun 30, 2012 | ($133.0K) | Oct 24, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Jun 30, 2016 | 79.45M | Sep 28, 2016 |
| FY2016 | Jun 30, 2016 | $11.96M | Sep 28, 2016 |
| FY2015 | Jun 30, 2015 | $22.06M | Sep 25, 2015 |
| FY2016 | Jun 30, 2015 | 134.35M | Sep 28, 2016 |
| FY2014 | Jun 30, 2014 | $25.11M | Sep 29, 2014 |
| FY2015 | Jun 30, 2014 | 154.53M | Sep 25, 2015 |
| FY2014 | Jun 30, 2013 | 135.47M | Sep 29, 2014 |
| FY2013 | Jun 30, 2013 | $21.89M | Sep 27, 2013 |
| FY2013 | Jun 30, 2012 | 152.15M | Sep 27, 2013 |
| FY2012 | Jun 30, 2012 | $24.08M | Oct 24, 2012 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Jun 30, 2013 | 46.74M | Sep 27, 2013 |
| FY2013 | Jun 30, 2013 | $7.55M | Sep 27, 2013 |
| FY2013 | Jun 30, 2012 | 65.91M | Sep 27, 2013 |
| FY2012 | Jun 30, 2012 | $10.43M | Oct 24, 2012 |
| FY2012 | Jun 30, 2011 | 26.90M | Oct 24, 2012 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Jun 30, 2016 | 41.38M | Sep 28, 2016 |
| FY2016 | Jun 30, 2016 | $6.23M | Sep 28, 2016 |
| FY2016 | Jun 30, 2015 | 74.05M | Sep 28, 2016 |
| FY2015 | Jun 30, 2015 | $12.16M | Sep 25, 2015 |
| FY2015 | Jun 30, 2014 | 95.98M | Sep 25, 2015 |
| FY2014 | Jun 30, 2014 | $15.59M | Sep 29, 2014 |
| FY2014 | Jun 30, 2013 | 81.53M | Sep 29, 2014 |
| FY2013 | Jun 30, 2013 | $13.17M | Sep 27, 2013 |
| FY2013 | Jun 30, 2012 | 79.62M | Sep 27, 2013 |
| FY2012 | Jun 30, 2012 | $12.60M | Oct 24, 2012 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Jun 30, 2016 | (63.91M) | Sep 28, 2016 |
| FY2016 | Jun 30, 2016 | ($9.62M) | Sep 28, 2016 |
| FY2016 | Jun 30, 2015 | (23.02M) | Sep 28, 2016 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Jun 30, 2016 | 1.82M | Sep 28, 2016 |
| FY2016 | Jun 30, 2016 | $273.6K | Sep 28, 2016 |
| FY2016 | Jun 30, 2015 | 12.34M | Sep 28, 2016 |
| FY2016 | Jun 30, 2015 | $1.86M | Sep 28, 2016 |
| FY2015 | Jun 30, 2014 | $2.97M | Sep 25, 2015 |
| FY2016 | Jun 30, 2014 | 18.09M | Sep 28, 2016 |
| FY2014 | Jun 30, 2013 | $2.01M | Sep 29, 2014 |
| FY2015 | Jun 30, 2013 | 12.35M | Sep 25, 2015 |
| FY2014 | Jun 30, 2012 | 3.53M | Sep 29, 2014 |
| FY2013 | Jun 30, 2012 | $571.0K | Sep 27, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Jun 30, 2016 | (7) | Sep 28, 2016 |
| FY2016 | Jun 30, 2016 | (1) | Sep 28, 2016 |
| FY2015 | Jun 30, 2015 | (1) | Sep 25, 2015 |
| FY2016 | Jun 30, 2015 | (6) | Sep 28, 2016 |
| FY2014 | Jun 30, 2014 | 0 | Sep 29, 2014 |
| FY2015 | Jun 30, 2014 | 0 | Sep 25, 2015 |
| FY2014 | Jun 30, 2013 | 0 | Sep 29, 2014 |
| FY2013 | Jun 30, 2013 | 0 | Sep 27, 2013 |
| FY2013 | Jun 30, 2012 | 0 | Sep 27, 2013 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Jun 30, 2016 | (7) | Sep 28, 2016 |
| FY2016 | Jun 30, 2016 | (1) | Sep 28, 2016 |
| FY2015 | Jun 30, 2015 | (1) | Sep 25, 2015 |
| FY2016 | Jun 30, 2015 | (6) | Sep 28, 2016 |
| FY2014 | Jun 30, 2014 | 0 | Sep 29, 2014 |
| FY2015 | Jun 30, 2014 | 0 | Sep 25, 2015 |
| FY2013 | Jun 30, 2013 | 0 | Sep 27, 2013 |
| FY2014 | Jun 30, 2013 | 0 | Sep 29, 2014 |
| FY2013 | Jun 30, 2012 | 0 | Sep 27, 2013 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Jun 30, 2016 | 5.80M | Sep 28, 2016 |
| FY2016 | Jun 30, 2015 | 5.43M | Sep 28, 2016 |
| FY2015 | Jun 30, 2014 | 4.72M | Sep 25, 2015 |
| FY2014 | Jun 30, 2013 | 3.95M | Sep 29, 2014 |
| FY2013 | Jun 30, 2012 | 3.95M | Sep 27, 2013 |
| FY2012 | Jun 30, 2011 | 3.95M | Oct 24, 2012 |